Current Treatment Options in Oncology

Article	Citations
Role of Metastasis-Directed Therapy in Genitourinary Cancers	152
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer	110
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia	84
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies	70
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma	60
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead	55
An Update on Temporal Bone Paragangliomas	52
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions	51
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes	48
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect	45
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer	42
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors	40
Approach to Localized Squamous Cell Cancer of the Esophagus	40
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers	38
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?	37
Management of Fatigue in Patients with Advanced Cancer	33
Small Cell Lung Cancer—An Update on Chemotherapy Resistance	33
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma	33
The Role of Nursing in the Delivery of Cardio-Oncology	32
Regorafenib for the Treatment of Sarcoma	32
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer	31
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations	31
Advances in Targeted Therapy for Metastatic Prostate Cancer	29
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer	29
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities	28

Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs	27
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements	27
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia	27
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?	26
Recognition and Management of the Long-term Effects of Cranial Radiation	25
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?	25
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas	24
Gastric Cancer with Sarcopenia: an Area Worth Focusing On	24
Endocrinologic Toxicities of Cancer Therapy: Evolving Challenges and Multidisciplinary Approaches	24
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment	23
Research Progress on Ferroptosis in Multiple Myeloma	23
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis	22
Response Evaluation of Neoadjuvant Therapies in Sarcoma	22
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond	22
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer	21
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy	21
Novel Estrogen Receptor-Targeted Agents for Breast Cancer	21
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review	21
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors	20
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities	20
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker	20
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)	20
Contemporary Review of Adenocarcinoma of the Cervix	20
Treatment Options for Brain Metastases	20
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract	19
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer	19
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer	19
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers	19
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects	19
Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer	18
Progress in the Treatment of Small Intestine Cancer	18
Updates in Management of Malignant Pleural Mesothelioma	18
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer	18
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?	18
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease	18
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives	17
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma	17
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia	17
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation	17
The Dilemma of Treating Delirium: the Conundrum of Drug Management	17
Updates in Breast Cancer Screening and Diagnosis	17
The Role of Induction Therapy for Sinonasal Cancers	16
Advances in PSMA-Targeted Radionuclide Therapeutics	16
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations	16
Myxoid Liposarcomas: Systemic Treatment Options	16
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer	15
Correction to: Cardiotoxicity of Systemic Melanoma Treatments	15
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review	15
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective	15
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?	15

Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management	14
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies	14
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?	14
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer	14
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer	14
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy	14
The Role of SIRT1 in Leukemia	14
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus	14
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management	14
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance	14
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?	13
Advancements in Melanoma Therapies: From Surgery to Immunotherapy	13
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches	13
HER2-Positive Metastatic Colorectal Cancer	13
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming	13
Therapeutic Management of Malignant Wounds: An Update	12
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation	12
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic	12
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer	12
Management of Functional Pancreatic Neuroendocrine Neoplasms	12
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology	12
Targeted Therapy in Early Stage Non-small Cell Lung Cancer	12
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?	12
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches	12
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors	12
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions	12
Systemic Management of Advanced Adrenocortical Carcinoma	12
Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)	11
Current Surgical Management for Acral Melanoma	11
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes	11
Impact of PSMA PET on Prostate Cancer Management	11
Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma	11
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice	11
The Evolving Landscape of Ovarian Cancer: Innovations in Biotechnology and Artificial Intelligence- Based Screening and Treatment	11
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy	11
Community Palliative Care: What are the Best Models?	11
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?	11
Systemic and Targeted Therapies in Adenoid Cystic Carcinoma	11
The Role of Pharmacogenomics in Opioid Prescribing	11
Advanced Acral Melanoma Therapies: Current Status and Future Directions	11
Nanomedicine-Based Treatments for Rare and Aggressive Ocular Cancers: Advances in Drug Delivery	11
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer	11
Diagnosis and Treatment of Myxoid Liposarcoma	11
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas	11
Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy	10
Neuropathic Pain in Cancer: What Are the Current Guidelines?	10
The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer	10
Relapsed Synovial Sarcoma: Treatment Options	10
Current Drug Resistance Mechanisms and Treatment Options in Gastrointestinal Stromal Tumors: Summary and Update	10
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients	10
Antibody-Drug Conjugates in Gynecologic Cancers	10
Interventional Cardio-Oncology: Unique Challenges and Considerations in a High-Risk Population	10
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)	10
Central Nervous System Metastases in Breast Cancer	10
Dermatofibrosarcoma Protuberans (DFSP): Current Treatments and Clinical Trials	10
Central Nervous System Prophylaxis and Treatment in Acute Leukemias	10
Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies	10
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies	10
Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma	10
Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies	9
New Immuno-oncology Targets and Resistance Mechanisms	9
Correction to: Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy	9
Frontiers of Ovarian Carcinosarcoma	9
Not All Leiomyosarcomas Are the Same: How to Best Classify LMS	9
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?	9
The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies	9
Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms	9
Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review	9
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review	9
A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies	9
Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies	9
The Crying Need for a Better Response Assessment in Rectal Cancer	9
The Evolving Treatment Landscape of Merkel Cell Carcinoma	9
Skin Reactions and Other Underappreciated Dermatologic Side Effects of Cancer Therapies	8
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment	8
Angiosarcoma: Role of Immunotherapy	8
Combination Immunotherapy for Mucosal Melanoma: Molecular Mechanism, Research Status, and Future Directions	8
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy	8
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer	8
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML	8

Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma	8
Therapeutic Cancer Vaccines for Nonmelanoma Skin Cancer	8
PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance	8
Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer	8
Addressing Sexual Health in Breast Cancer Survivors: Evidence-Based Practices and Clinical Considerations	8
Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer	8
Surgery Matters: Progress in Surgical Management of Gastric Cancer	8
Pathogenic Mechanisms in Acute Myeloid Leukemia	7
Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review	7
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now	7
Whole Lung Irradiation in Ewing Sarcoma with Pulmonary Metastases: Critical Appraisal of Evolution, Evidence, and Future Pathways in Precision Oncology	7
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?	7
Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose	7
Immunotherapy in HPV-Related Oropharyngeal Cancers	7
Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future Fertility	7
Updates in Hormone Replacement Therapy for Survivors of Gynecologic Cancers	7
Research Progress on the Use of Metformin in Leukemia Treatment	7
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia	7
Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma	7
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials	7
Advanced Mucosal Melanoma Therapies: Current Status and Future Directions	7
Targeted Therapies in the Treatment of Uterine Serous Carcinoma	7
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?	7
Incorporating Molecular Diagnostics into Treatment Paradigms for Endometrial Cancer	7
Desmoid Tumors: Current Perspective and Treatment	7
State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors	7
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies	6
Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine	6
The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview	6
Cardio-oncology for Pediatric and Adolescent/Young Adult Patients	6
High-Dose Somatostatin Analogs for the Treatment of Neuroendocrine Neoplasms: where are we Now?	6
Research Priorities and Future Directions in Cardio-Oncology	6
Advances in Surgical Management of Malignant Tumors of the Distal Tibia	6
Role of Radiotherapy in PCNSL within the Current Therapeutic Landscape: a Comprehensive Review	6
Gene Mutations and Targeted Therapies of Myeloid Sarcoma	6
The Current Cardio-Oncology Landscape Across Australia	6
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)	6
Molecular Secrets Revealed: How Diabetes may be Paving the Way for Leukemia	6
What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?	6
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma	6
Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer	6
Beyond Serous: Treatment Options for Rare Endometrial Cancers	6
Emerging Advances in the Molecular Landscape of Penile Cancer and Their Implications for Precision Medicine	6
Cardio-Oncology and Breast Cancer Therapies	6
Increasing Diversity in Head and Neck Cancer Clinical Trials	6
Targeted Therapy and Immunotherapy in Elderly Patients with Metastatic Colorectal Cancer	6
Respiratory Depression Associated with Opioids: A Narrative Review	6